CRYZ and Parkinson disease: Luo et al. revealed that AKT could directly bind to the antioxidative enzyme, quinone oxidoreductase (NQO1), which further phosphorylated NQO1 and promoted its polyubiquitination and degradation, decreasing the ability of cells to counteract oxidative stress in PD [39].